Cargando…
P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13
Autores principales: | Pfeifer, Heike, Lang, Fabian, Fiedler, Walter, Stelljes, Matthias, Schneller, Folker, Steffen, Björn, Böll, Boris, Viardot, Andreas, Faul, Christoph, Lars Teichmann, Lino, Poeck, Hendrik, Westermann, Jörg, Schaefer-Eckart, Kerstin, Heinicke, Thomas, Serve, Hubert, Brüggemann, Monika, Schwartz, Stefan, Burmeister, Thomas, Gökbuget, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428364/ http://dx.doi.org/10.1097/01.HS9.0000968332.33834.d6 |
Ejemplares similares
-
S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
por: Lang, Fabian, et al.
Publicado: (2023) -
P1180: BURKITT INTERNATIONAL PROGNOSTIC INDEX EVALUATED IN PATIENTS TREATED WITH R-GMALL PROTOCOL
por: Rizzuto, Giuliana, et al.
Publicado: (2023) -
Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
por: Kobitzsch, Benjamin, et al.
Publicado: (2017) -
Imatinib Treatment Alone in Philadelphia-Positive Acute Lymphoblastic Leukemia: Is It Enough?
por: Ay, Yilmaz, et al.
Publicado: (2010) -
Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
por: Singh, Surjit, et al.
Publicado: (2016)